SLSN_OUT_1 [2025-04-28 12:36:13 -0400] 2407 Bytes | 560 tokens | Cum: 560 tkns (7.00% of 8k)
==========================================================================

Booyah, my friends! It's already 12:36 PM on Mon Apr 28, 2025, and I've got my eyes locked on Solesence (SLSN), pushing up to $2.96 from $2.49. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

--- COMPANY PROFILE ---
Company: Solesence (SLSN)
IPO: 1997-11-26 (27 Years Ago)
Market Cap: $135,299,328
Shares Outstanding: 70,100,000
Industry: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Exchange: XNAS
Description: Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.

Here’s a list of headlines for Solesence:

No news available.

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Solesence (SLSN).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

SLSN_OUT_3 [2025-04-28 12:36:14 -0400] 812 Bytes | 262 tokens | Cum: 824 tkns (10.30% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-09T12:06:00Z - Pre-market Movers: VERO, WORX, GFR, ALTG, QLGN....
A2 - 2025-04-07T20:12:00Z - Solésence, Inc.: Solésence Announces Uplisting to Nasdaq...
A3 - 2025-04-07T20:14:07Z - Solésence moves to Nasdaq with new ticker SLSN By Investing.com...
A4 - 2025-04-07T20:14:07Z - Solésence moves to Nasdaq with new ticker SLSN By Investing.com...
A5 - 2025-04-07T20:16:36Z - Solésence Announces Uplisting to Nasdaq...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

SLSN_OUT_5 [2025-04-28 12:36:15 -0400] 1181 Bytes | 429 tokens | Cum: 1255 tkns (15.69% of 8k)
==========================================================================

Showing A1 (chunk 1 of 2): A1:
**Pre-market Movers: VERO, WORX, GFR, ALTG, QLGN.**Date: 2025-04-09Source: {'uri': 'finanznachrichten.de', 'dataType': 'news', 'title': 'FinanzNachrichten.de'}URL: https://www.finanznachrichten.de/nachrichten-2025-04/65069588-pre-market-movers-vero-worx-gfr-altg-qlgn-020.htmOTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.25 A.M. ET).

In the Green

Venus Concept Inc (VERO) is up over 310% at $11.82. Scworx Corp (WORX) is up over 82% at $1.45. Femto Technologies Inc (FMTO) is up over 45% at $4.09. ENDRA Life Sciences Inc (NDRA) is up over 22% at $4.88. Basel Medical Group (BMGL) is up over 20% at $4.99. Peabody Energy Corp (BTU) is up over 19% at $13.43. Upexi Inc (UPXI) is up over 14% at $2.49. Gamehaus Holdings Inc (GMHS) is up over 13% at $1.42. Solesence Inc (SLSN) is up over 11% at $1.99. CervoMed Inc (CRVO) is

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SLSN_OUT_7 [2025-04-28 12:36:16 -0400] 1020 Bytes | 356 tokens | Cum: 1613 tkns (20.16% of 8k)
==========================================================================

Showing A1 (chunk 2 of 2): up over 9% at $9.07. Landsea Homes Corp (LSEA) is up over 9% at $6.20.

In the Red

Greenfire Resources Ltd (GFR) is down over 57% at $2.00. Alta Equipment Group Inc (ALTG) is down over 54% at $1.80. Qualigen Therapeutics Inc (QLGN) is down over 50% at $1.50. Atea Pharmaceuticals Inc (AVIR) is down over 32% at $1.80. Performant Financial Corporation (PHLT) is down over 24% at $1.90. Perma-Fix Environmental Svcs Inc (PESI) is down over 23% at $5.00. NanoVibronix Inc (NAOV) is down over 22% at $5.60. Fatpipe Inc (FATN) is down over 21% at $10.15. FST Ltd (KBSX) is down over 19% at $1.27. MasterBrand Inc (MBC) is down over 9% at $10.10.

Copyright(c) 2025 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX© 2025 AFX News

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SLSN_OUT_9 [2025-04-28 12:36:17 -0400] 1081 Bytes | 298 tokens | Cum: 1913 tkns (23.91% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-07 8-K Item 7.01. Regulation FD Disclosure.

On April 7, 2025, Solesence, Inc. (the Company) issued a press release regarding its uplisting to The NASDAQ Stock Market LLC (the Press Release). Pursuant to Item 7.01 of Form 8-K, a copy of the Press Release is furnished as Exhibit 99.1 to...

S2 - 2025-03-31 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper

The following discussion and analysis should be read in conjunction with risks discussed in the financial statements and related notes thereto appearing elsewhere in this Form 10-K. Wh...

S3 - 2024-11-12 10-Q PART I FIN INFO

Item 1. Fin Stmnts

NANOPHASE TECHNOLOGIES CORPORATION

CONS BAL SHEETS

(Unaudited Cons Condensed)

(in thousands except share and per share data) ASSETS September 30, 2024 December 31, 2023 Curr assets: Cash...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

SLSN_OUT_11 [2025-04-28 12:36:18 -0400] 1181 Bytes | 295 tokens | Cum: 2210 tkns (27.62% of 8k)
==========================================================================

Showing S1 (chunk 1 of 2): S1:
Item 7.01. Regulation FD Disclosure.

On April 7, 2025, Solesence, Inc. (the Company) issued a press release regarding its uplisting to The NASDAQ Stock Market LLC (the Press Release). Pursuant to Item 7.01 of Form 8-K, a copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01 and Item 9.01, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of such section, nor shall it be deemed incorporated by reference in any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in any such filing, unless expressly incorporated by specific reference in such filing.

Forward-Looking Statements

Certain statements in this Current Report o

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SLSN_OUT_13 [2025-04-28 12:36:18 -0400] 801 Bytes | 177 tokens | Cum: 2389 tkns (29.86% of 8k)
==========================================================================

Showing S1 (chunk 2 of 2): n Form 8-K are forward-looking statements that involve a number of risks and uncertainties. For such statements, the Company claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from the Companys expectations. Additional factors that could cause actual results to differ materially from those stated or implied by the Companys forward-looking statements are disclosed in the Companys reports filed with the Securities and Exchange Commission....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

SLSN_OUT_15 [2025-04-28 12:36:26 -0400] 4880 Bytes | 1177 tokens | Cum: 3568 tkns (44.60% of 8k)
==========================================================================

This is our set of metrics for Solesence.
Please analyze the numbers.

+---------------------+----------------------+------------------------+-----------------------+
| Volume: 55,026 | Perf Month: 20.04% | Option/Short: No / Yes | Sales Y/Y TTM: 40.35% |
+---------------------+----------------------+------------------------+-----------------------+
| Avg Volume: 103.13K | Perf Quarter: -5.33% | Short Float: 0.05% | ROE: 50.28% |
+---------------------+----------------------+------------------------+-----------------------+
| Rel Volume: 1.15 | Index: - | Short Ratio: 0.08 | ROI: 17.66% |
+---------------------+----------------------+------------------------+-----------------------+
| RSI (14): 66.35 | Market Cap: 196.03M | Short Interest: 0.01M | Sales Surprise: - |
+---------------------+----------------------+------------------------+-----------------------+
| ATR (14): 0.70 | Shs Outstand: 70.10M | Beta: 0.81 | EPS Surprise: - |
+---------------------+----------------------+------------------------+-----------------------+
| SMA20: 32.84% | Shs Float: 17.22M | Sales Q/Q: 56.87% | P/E: 43.55 |
+---------------------+----------------------+------------------------+-----------------------+
| SMA50: 15.68% | Inst Own: 0.02% | Sales past 5Y: 35.19% | Earnings: - |
+---------------------+----------------------+------------------------+-----------------------+
| SMA200: 32.46% | Insider Own: 75.40% | Employees: 98 | |
+---------------------+----------------------+------------------------+-----------------------+
| Perf Week: 24.44% | Insider Trans: 0.00% | Debt/Eq: 1.02 | |
+---------------------+----------------------+------------------------+-----------------------+

The next section covers any insider trading by Solesence officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 3
Average Volume: 317932.57
30-Day High: 3
30-Day Low: 1.68
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Solesence (SLSN).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Solesence.

2) MARKET_SCORE[]
This conversation was initiated because SLSN is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for SLSN.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, SLSN could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect SLSN to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Solesence.

11) ETHICAL_RATING[]
Rate Solesence’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Solesence.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

SLSN_IN_17 [2025-04-28 12:36:26 -0400] 126 Bytes | 29 tokens | Cum: 3795 tkns (47.44% of 8k)
==========================================================================

====================================
[2025-04-28 12:36:26] # Analysis Completed
Elapsed Time: 13.83 seconds